Rheumatic mitral aggression. Usefulness of 3D transesophageal echocardiography
DOI:
https://doi.org/10.47487/apcyccv.v3i2.211Keywords:
Rheumatic Heart Disease, Mitral Valve, Mitral Valve Stenosis, Echocardiography, TransesophagealAbstract
Rheumatic heart disease is the leading cause of cardiovascular disease in young adults under 25 years of age worldwide, with the highest prevalence in low-income countries. The usual and distinctive finding of rheumatic aggression is mitral stenosis, which leads to serious cardiovascular consequences. International guidelines establish transthoracic echocardiography (TTE) as the diagnostic test for rheumatic heart disease; however, it has limitations in the measurement of planimetry and those inherent to Doppler. Transesophageal 3D echocardiography (TTE-3D) is a new modality that shows realistic images of the mitral valve and has the added value of accurately locating the plane of maximum stenosis and better determining commissural involvement.
Downloads
Downloads
- PDF (Spanish)
- EPUB (Spanish)
- Video 1 (Spanish)
- Video 2 (Spanish)
- Video 3 (Spanish)
- Video 4 (Spanish)
- Video 5 (Spanish)
- Video 6 (Spanish)
- Video 7 (Spanish)
- Video 8 (Spanish)
- Video 9 (Spanish)
- Video 10 (Spanish)
- Video 11 (Spanish)
- Video 12 (Spanish)
- Video 13 (Spanish)
- Video 14 (Spanish)
- Video 15 (Spanish)
- Video 16 (Spanish)
- Video 17 (Spanish)
- Video 18 (Spanish)
- Video 19 (Spanish)
- Video 20 (Spanish)
- Video 21 (Spanish)
- Video 22 (Spanish)
- Video 23 (Spanish)
- Video 24 (Spanish)
- Video 25 (Spanish)
- Video 26 (Spanish)
- Video 27 (Spanish)
Published
Issue
Section
License
Copyright (c) 2022 The journal is headline of the first publication, then the author giving credit to the first publication.
This work is licensed under a Creative Commons Attribution 4.0 International License.